| Year |
Citation |
Score |
| 2008 |
van Luijn JC, van Loenen AC, Gribnau FW, Leufkens HG. Choice of comparator in active control trials of new drugs. The Annals of Pharmacotherapy. 42: 1605-12. PMID 18957629 DOI: 10.1345/Aph.1L115 |
0.366 |
|
| 2005 |
Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Annals of the Rheumatic Diseases. 64: 127-9. PMID 15051621 DOI: 10.1136/Ard.2004.020503 |
0.591 |
|
| 2000 |
van Kraaij DJ, Jansen RW, Bouwels LH, Gribnau FW, Hoefnagels WH. Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. The American Journal of Cardiology. 85: 1461-6. PMID 10856393 DOI: 10.1016/S0002-9149(00)00795-5 |
0.311 |
|
| 1998 |
van Kraaij DJ, Jansen RW, Gribnau FW, Hoefnagels WH. Use of diuretics and opportunities for withdrawal in a Dutch nursing home population. The Netherlands Journal of Medicine. 53: 20-6. PMID 9718938 DOI: 10.1016/S0300-2977(98)00053-9 |
0.308 |
|
| 1998 |
van Kraaij DJ, Jansen RW, Gribnau FW, Hoefnagels WH. Loop diuretics in patients aged 75 years or older: general practitioners' assessment of indications and possibilities for withdrawal. European Journal of Clinical Pharmacology. 54: 323-7. PMID 9696957 DOI: 10.1007/S002280050467 |
0.345 |
|
| 1997 |
van Kraaij DJ, Jansen RW, Bruijns E, Gribnau FW, Hoefnagels WH. Diuretic usage and withdrawal patterns in a Dutch geriatric patient population. Journal of the American Geriatrics Society. 45: 918-22. PMID 9256841 DOI: 10.1111/J.1532-5415.1997.Tb02959.X |
0.327 |
|
| 1997 |
Meyboom RH, Egberts AC, Edwards IR, Hekster YA, de Koning FH, Gribnau FW. Principles of signal detection in pharmacovigilance. Drug Safety. 16: 355-65. PMID 9241490 DOI: 10.2165/00002018-199716060-00002 |
0.302 |
|
| 1996 |
Creemers MC, van 't Hof MA, Franssen MJ, van de Putte LB, Gribnau FW, van Riel PL. Disease activity in ankylosing spondylitis: selection of a core set of variables and a first set in the development of a disease activity score. British Journal of Rheumatology. 35: 867-73. PMID 8810670 DOI: 10.1093/Rheumatology/35.9.867 |
0.591 |
|
| 1996 |
Meyboom R, Gribnau F, Hekster Y, de Koning G, Egberts A. Characteristics of Topics in Pharmacovigilance in The Netherlands† Clinical Drug Investigation. 12: 207-219. DOI: 10.2165/00044011-199612040-00006 |
0.302 |
|
| 1995 |
Creemers MC, Franssen MJ, van de Putte LB, Gribnau FW, van Riel PL. Methotrexate in severe ankylosing spondylitis: an open study. The Journal of Rheumatology. 22: 1104-7. PMID 7674237 |
0.638 |
|
| 1994 |
van Meyel JJ, Smits P, Dormans T, Gerlag PG, Russel FG, Gribnau FW. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. Journal of Internal Medicine. 235: 329-34. PMID 8151264 DOI: 10.1097/00132586-199412000-00064 |
0.313 |
|
| 1994 |
Creemers MC, Van 't Hof MA, Franssen MJ, Van de Putte LB, Gribnau FW, Van Riel PL. A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study. British Journal of Rheumatology. 33: 842-6. PMID 8081670 DOI: 10.1093/Rheumatology/33.9.842 |
0.633 |
|
| 1994 |
van Kraaij DJ, Haagsma CJ, Go IH, Gribnau FW. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. The Netherlands Journal of Medicine. 44: 166-73. PMID 8028691 DOI: 10.1016/0300-2977(95)90003-9 |
0.307 |
|
| 1994 |
Russel FG, Creemers MC, Tan Y, van Riel PL, Gribnau FW. Ion-pair solid-phase extraction of cimetidine from plasma and subsequent analysis by high-performance liquid chromatography. Journal of Chromatography. B, Biomedical Applications. 661: 173-7. PMID 7866547 DOI: 10.1016/0378-4347(94)00320-3 |
0.444 |
|
| 1994 |
Creemers MC, van Riel PL, Franssen MJ, van de Putte LB, Gribnau FW. Second-line treatment in seronegative spondylarthropathies. Seminars in Arthritis and Rheumatism. 24: 71-81. PMID 7839156 DOI: 10.1016/S0049-0172(05)80001-0 |
0.611 |
|
| 1992 |
Van Meyel JJ, Gerlag PG, Smits P, Russel FG, Tan Y, Van Ginneken CA, Gribnau FW. Absorption of high dose furosemide (frusemide) in congestive heart failure. Clinical Pharmacokinetics. 22: 308-18. PMID 1606790 DOI: 10.2165/00003088-199222040-00006 |
0.314 |
|
| 1991 |
Jacobs JW, Rasker JJ, Van Riel PL, Gribnau FW, van de Putte LB. [Alternative treatment methods in rheumatic diseases; a literature review]. Nederlands Tijdschrift Voor Geneeskunde. 135: 317-22. PMID 2008219 |
0.613 |
|
| 1991 |
Jacobs JW, Rasker JJ, van Riel PL, Gribnau FW, van de Putte LB. Rheumajecta and vasolastine in the treatment of rheumatoid arthritis--the results of a placebo-controlled, double-blind trial of a complementary treatment. Scandinavian Journal of Rheumatology. 20: 434-40. PMID 1771401 DOI: 10.3109/03009749109096823 |
0.657 |
|
| 1991 |
Wijnands MJ, Nuver-Zwart IH, van Riel PL, van 't Hof MA, Gribnau FW, van De Putte LB. Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients. Scandinavian Journal of Rheumatology. 20: 52-7. PMID 1672775 DOI: 10.3109/03009749109165922 |
0.617 |
|
| 1990 |
Wijnands MJ, van Riel PL, Gribnau FW, van de Putte LB. [Risk factors for the development of side effects during treatment of rheumatoid arthritis with second-line antirheumatic agents; a review of the literature]. Nederlands Tijdschrift Voor Geneeskunde. 134: 1387-91. PMID 2197565 |
0.582 |
|
| 1990 |
Wijnands MJ, van Riel PL, Gribnau FW, van de Putte LB. Risk factors of second-line antirheumatic drugs in rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 19: 337-52. PMID 2196675 DOI: 10.1016/0049-0172(90)90071-M |
0.569 |
|
| 1990 |
Jacobs JW, Rasker JJ, van Riel PL, Gribnau FW, van de Putte LB. [Rheumajecta and Vasolastine treatment of primary fibromyalgia; results of a randomized placebo-controlled double-blind study]. Nederlands Tijdschrift Voor Geneeskunde. 134: 693-7. PMID 2157988 |
0.559 |
|
| 1989 |
Nuver-Zwart IH, van Riel PL, van de Putte LB, Gribnau FW. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Annals of the Rheumatic Diseases. 48: 389-95. PMID 2567150 DOI: 10.1136/Ard.48.5.389 |
0.664 |
|
| 1989 |
van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1: 1036-8. PMID 2565997 |
0.516 |
|
| 1988 |
Van den Ouweland FA, Jansen PA, Tan Y, Van de Putte LB, Van Ginneken CA, Gribnau FW. Pharmacokinetics of high-dosage naproxen in elderly patients. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 26: 143-7. PMID 3410597 |
0.473 |
|
| 1988 |
Van den Ouweland FA, Gribnau FW, Meyboom RH. Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly. Age and Ageing. 17: 8-16. PMID 3364313 DOI: 10.1093/Ageing/17.1.8 |
0.334 |
|
| 1988 |
Van den Ouweland FA, Gribnau FW, Van Ginneken CA, Tan Y, Van de Putte LB. Naproxen kinetics and disease activity in rheumatoid arthritis: a within-patient study. Clinical Pharmacology and Therapeutics. 43: 79-85. PMID 3335121 DOI: 10.1038/Clpt.1988.14 |
0.526 |
|
| 1988 |
van Riel PL, Nuver-Zwart HH, van de Putte LB, Gribnau FW. [Sulfasalazine as an antirheumatism agent; a review of the literature]. Nederlands Tijdschrift Voor Geneeskunde. 132: 594-5. PMID 2896302 |
0.513 |
|
| 1987 |
van den Ouweland FA, Franssen MJ, van de Putte LB, Tan Y, van Ginneken CA, Gribnau FW. Naproxen pharmacokinetics in patients with rheumatoid arthritis during active polyarticular inflammation. British Journal of Clinical Pharmacology. 23: 189-93. PMID 3828195 |
0.501 |
|
| 1987 |
Van den Ouweland FA, Gribnau FW. Nonsteroidal anti-inflammatory drugs as a prognostic factor in acute pulmonary edema. Archives of Internal Medicine. 147: 176, 179. PMID 3800522 DOI: 10.1001/Archinte.1987.00370010174040 |
0.321 |
|
| 1987 |
Van Riel PL, Gribnau FW, Van de Putte LB, Arts CW, Van Aernsbergen A. Serum gold concentrations during treatment with auranofin. Clinical Rheumatology. 6: 50-4. PMID 3581698 DOI: 10.1007/Bf02201000 |
0.621 |
|
| 1987 |
van den Ouweland FA, Corstens FH, van de Putte LB, Gribnau FW. Gastrointestinal blood loss during treatment with naproxen for rheumatoid arthritis. Scandinavian Journal of Rheumatology. 16: 365-70. PMID 3500510 DOI: 10.3109/03009748709102509 |
0.55 |
|
| 1986 |
Van den Ouweland FA, Gribnau FW, Tan Y, Van Ginneken CA, Van de Putte LB. Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis. Clinical Pharmacokinetics. 11: 511-5. PMID 3802691 DOI: 10.2165/00003088-198611060-00007 |
0.566 |
|
| 1986 |
Jansen PA, Schulte BP, Meyboom RH, Gribnau FW. Antihypertensive treatment as a possible cause of stroke in the elderly. Age and Ageing. 15: 129-38. PMID 3526836 DOI: 10.1093/Ageing/15.3.129 |
0.305 |
|
| 1986 |
Franssen MJ, Gribnau FW, van de Putte LB. A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis. Clinical Rheumatology. 5: 210-20. PMID 3524970 DOI: 10.1007/Bf02032359 |
0.407 |
|
| 1986 |
Van Riel PL, Larsen A, Van de Putte LB, Gribnau FW. Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Clinical Rheumatology. 5: 359-64. PMID 3096626 DOI: 10.1007/Bf02054254 |
0.569 |
|
| 1986 |
Jansen PA, Gribnau FW, Schulte BP, Poels EF. Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly. British Medical Journal (Clinical Research Ed.). 293: 914-7. PMID 3094713 DOI: 10.1136/Bmj.293.6552.914 |
0.305 |
|
| 1985 |
Franssen MJ, van de Putte LB, Gribnau FW. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Annals of the Rheumatic Diseases. 44: 766-71. PMID 4062389 DOI: 10.1136/ard.44.11.766 |
0.478 |
|
| 1985 |
Friesen WT, Hekster YA, van de Putte LB, Gribnau FW. Cross-sectional study of rheumatoid arthritis treatment in a university hospital. Annals of the Rheumatic Diseases. 44: 372-8. PMID 3874606 DOI: 10.1136/Ard.44.6.372 |
0.586 |
|
| 1984 |
van Riel PL, van de Putte LB, Gribnau FW, de Waal RM. IgA deficiency during aurothioglucose treatment. A case report. Scandinavian Journal of Rheumatology. 13: 334-6. PMID 6441247 DOI: 10.3109/03009748409111305 |
0.601 |
|
| 1984 |
van Riel PL, van de Putte LB, Gribnau FW, Macrae KD. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study. Clinical Rheumatology. 3: 51-6. PMID 6432414 DOI: 10.1007/Bf03342622 |
0.594 |
|
| 1984 |
Van Riel PL, van de Putte LB, Gribnau FW, de Waal RM. Serum IgA and gold-induced toxic effects in patients with rheumatoid arthritis. Archives of Internal Medicine. 144: 1401-3. PMID 6428342 DOI: 10.1001/Archinte.144.7.1401 |
0.571 |
|
| 1983 |
van Riel PL, Reekers P, van de Putte LB, Gribnau FW. Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens. 22: 194-9. PMID 6415865 DOI: 10.1111/J.1399-0039.1983.Tb01191.X |
0.632 |
|
| 1983 |
van Riel PL, Gribnau FW, van de Putte LB. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination. The Journal of Rheumatology. 10: 574-8. PMID 6413685 |
0.459 |
|
| 1983 |
van Riel PL, Gribnau FW, van de Putte LB, Yap SH. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities. The Journal of Rheumatology. 10: 222-6. PMID 6408256 |
0.479 |
|
| 1981 |
Kerremans A, Majoor CL, Gribnau FW. Hypersensitivity to ethambutol. Tubercle. 62: 215-7. PMID 7314255 |
0.611 |
|
| Show low-probability matches. |
